Premium
Non‐pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells
Author(s) -
Magerl Markus,
Lammel Verena,
Siebenhaar Frank,
Zuberbier Torsten,
Metz Martin,
Maurer Marcus
Publication year - 2008
Publication title -
experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.108
H-Index - 96
eISSN - 1600-0625
pISSN - 0906-6705
DOI - 10.1111/j.1600-0625.2008.00704.x
Subject(s) - degranulation , bacteria , escherichia coli , microbiology and biotechnology , pathogenic bacteria , biology , pathogenic escherichia coli , mast cell , immune system , immunology , biochemistry , genetics , receptor , gene
Background: The mast cell’s (MC) ability to rapidly release presynthesized mediators allows it to play a critical role in the immune system’s first‐line response to pathogens. Although recent research has illuminated the role of MCs in bacterial infection, little is known about how non‐pathogenic bacteria influence MC responses. Objective: To characterize the influence of non‐pathogenic Escherichia coli bacteria on MCs. Results: High concentrations of live E. coli strongly down‐modulated the degranulation of murine peritoneal MCs under all activator conditions. Bacteria did not induce MC degranulation by themselves, and staining of MCs showed they were still entirely viable. Dead bacteria and bacterial supernatant had no effect on MC degranulation. Ex vivo experiments confirmed that E. coli exposure down‐modulates subsequently induced MC degranulation and that this effect lasts for up to a few days after exposure. Conclusion: Our results show that high doses of non‐pathogenic E. coli bacteria can function as a strong, direct inhibitor of MC degranulation. This suggests a possible basis for future antiallergic treatment or prophylaxis with commensal bacteria, i.e. probiotics.